Back

Prognostic importance of guideline-directed medical therapy after left ventricular assist devices: a 10-year single-centre experience

11 May 2026 (10:30 - 11:15)
Organised by: Logo
Congress Presentation Part of: Advanced mechanical support: left ventricular assist device and mechanical support care (2) Ventricular Assist Devices HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Ewa Dziewiecka

John Paul II Specialist Hospital, Krakow (Poland)

5 More presentations in this session

Presentation thumbnail
Response of LVAD pump parameters to an orthostatic challenge and its association with CPET outcomes
Ms M. Wosten (Utrecht, NL)
Abstract Slides Video
Presentation thumbnail
Prediction of in-hospital mortality in left ventricular assist device recipients
Professor O. Karaca (Istanbul, TR)
Abstract Slides Video
Presentation thumbnail
Temporal interplay between right ventricular failure and aortic insufficiency after left ventricular assist device implantation
Doctor J. Guzman Bofarull (London, GB)
Abstract Slides Video
Presentation thumbnail
Association between early post-implantation pulmonary vascular resistance and clinical outcomes after LVAD implantation
Doctor H. Oh (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Trends in mortality and use of heart transplantation and left ventricular assist devices in advanced heart failure patients between 2003 and 2022: data from the swedish heart failure registry
Doctor F. Guidetti (Bern, CH)
Abstract Slides Video

Access the full session

Session thumbnail
Advanced mechanical support: left ventricular assist device and mechanical support care (2)

The Event

Event poster

Heart Failure 2026

11 May 2026 10:30 CET
You may be interested in
thumbnail
Congress Presentation
Temporal trends in the utilization of heart failure medical therapy in LVAD-supported advanced heart failure patients: a single center experience
thumbnail
Congress Presentation
Can heart failure guideline-directed medical therapy improve left ventricular assist device outcomes?
thumbnail
Congress Presentation
All LVAD patients must be treated with guideline-directed medical therapy: pro

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources